The influence of Glutamine in the Immunological system of patients with HIV/AIDS

niversidade Federal de Mato Grosso0 个研究点开始时间: 2018年9月18日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•The study included patients considered to be adherent to the treatment, both men and women, between 18 and 50 years of age with positive serology for HIV/AIDS, enrolled in this unit, in regular treatment / follow-up and in the use of antiretroviral drugs (zidovudine / lamivudine and lopinavir / ritonavir) for at least two years, with Global Subjective Assessment = A (well nourished), who accepted to participate in the research with prior signature of the Informed Consent Term (TCLE)

•Exclusion criterion were: patients who started treatment less than 2 years ago; with comorbidities; with a history of gastrointestinal tract operations; who used drugs that induced metabolic changes, as well as drug addicts and alcoholics. Also excluded were clinically severe or unstable patients, in addition to pregnant or infants; people with some mental disorder; who used glutamine or other supplement; patients with Global Subjective Evaluation B or C (moderately undernourished or severely undernourished) and patients who did not agree to participate in the study or did not sign the consent form.

发起方

niversidade Federal de Mato Grosso